<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT931-13609</title>
	</head>
	<body>
		<main>
			<p>930122 FT  22 JAN 93 / International Company News: Bristol-Myers gains 9% in final quarter BRISTOL-MYERS Squibb, one of the world's biggest pharmaceuticals companies, increased underlying fourth-quarter earnings by 9 per cent to Dollars 540m, or Dollars 1.05 a share. Figures were muddied by one-time items, including expenses from adoption of the new accounting standard, restructuring charges and the sale of its Drackett household products unit. Including these items, fourth-quarter net earnings were Dollars 583m, or Dollars 1.13, against Dollars 510m, or 98 cents, a year ago. Sales were flat at Dollars 2.8bn. Although international sales rose 8 per cent in the quarter, domestic sales fell 5 per cent, reflecting a decline in pharmaceuticals sales. For 1992, net income was Dollars 1.96bn, or Dollars 3.79, against Dollars 2.06bn, or Dollars 3.95. Stripping out special items, Bristol-Myers said its 1992 net profits increased 7 per cent to Dollars 2.12bn, or Dollars 4.10. Sales rose 6 per cent to Dollars 11.2bn, excluding sales from Drackett. During the fourth quarter, the company took pre-tax restructuring charges of Dollars 890m and charges of Dollars 390m for new accounting standards. The sale of Drackett brought in Dollars 952m before taxes. Pfizer, a US ethical pharmaceutical producer, posted a 39 per cent improvement in fourth-quarter net earnings from operations, reflecting the strength of several new drugs. Stripping out one-time items, Pfizer earned Dollars 264.8m, or 80 cents in the quarter. Including extraordinary items, Pfizer reported fourth-quarter net income of Dollars 278.8m, or 83 cents. Pfizer, which has not yet settled the litigation surrounding its Shiley heart valves, took a 58 cents a share charge for potential heart valve fracture claims in the 1991 fourth quarter which brought net income for the period to Dollars 900,000 or Dollars 0.00 a share. Sales in the latest quarter stood at 1.95bn up 5 per cent from Dollars 1.85bn.</p>
		</main>
</body></html>
            